AAVantgarde Bio

Milano, Italy

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

$141.0M raised

Nov 2025

Series B

Biotechnology Health Care Life Science Therapeutics

Top Investors

CDP Venture CapitalSchroders CapitalSofinnova PartnersForbion Capital PartnersLongwood Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AAVantgarde Bio

How much funding has AAVantgarde Bio raised?

AAVantgarde Bio has raised $141.0M in total funding. The most recent round was Series B. The last funding was announced in November 2025.

Who are AAVantgarde Bio's investors?

AAVantgarde Bio's investors include CDP Venture Capital, Schroders Capital, Sofinnova Partners, Forbion Capital Partners, Longwood Fund.

Where is AAVantgarde Bio headquartered?

AAVantgarde Bio is headquartered in Milano, Italy.

What does AAVantgarde Bio do?

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

What stage is AAVantgarde Bio at?

AAVantgarde Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 3, 2025.

MLA

"AAVantgarde Bio — Funding & Investors." VCBacked, November 3, 2025, https://www.vcbacked.co/company/aavantgarde-bio. Accessed June 3, 2026.

APA

VCBacked. (2025). AAVantgarde Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/aavantgarde-bio

Wikipedia (cite web)

{{cite web |title=AAVantgarde Bio — Funding & Investors |url=https://www.vcbacked.co/company/aavantgarde-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 3, 2025.

Similar Companies in Biotechnology